Knocking on Your Virtual Door: A Guide to FDA’s Remote Regulatory Assessments

article image

FDA’s medical device inspection branch officially launched what it calls the “Remote Regulatory Assessments” program in February. Trang Cox, a device inspector at FDA, recently provided an overview of how to participate in the program and what to expect.

FDA dispensed with routine onsite inspections in the early days of the pandemic, but it is only in the past few months that the agency’s device inspection cadre has launched an official program for conducting remote audits. The Remote Regulatory Assessments (RRA) program was stood up by the medical device section of FDA’s Office of Regulatory Affairs in mid-February.

This article is restricted to subscribers only.

To continue reading, select one of the options below:

Existing Subscriber?

Sign In to continue reading.

Need Multi-User Access?

Gain access for your entire organization.

Get Quote Check to see if your company already has access

Subscribe to Market Pathways:

Actionable intelligence exploring the people, challenges, and opportunities impacting the global medtech community.

Subscribe to Market Pathways
Subscribe to ELITE Strategist

Become an ELITE Strategist and unlock access to both MedTech Strategist and MTS Market Pathways.

Subscribe to Elite


We're here to help! Please contact us at: